Hints and tips:
Related Special Reports
...Chief executives at AbbVie, Eli Lilly, and Johnson & Johnson all earned more than Soriot in 2023....
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
...High demand for weight-loss drugs has helped Novo Nordisk become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s largest pharmaceutical company...
...reality even higher still as the top 10 includes two separate share classes of Alphabet, the parent of Google, alongside five of the other so-called Magnificent Seven stocks and three other US companies: Eli...
...In the past year, Novo Nordisk has become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s most valuable pharma company, on the back of high demand...
...This week it leapfrogged Johnson & Johnson and UnitedHealth to become the world’s most valuable drugmaker and healthcare company by market capitalisation....
...Johnson & Johnson is fighting a bruising battle over tens of thousands of claims its talcum powder caused cancer....
...Over the past 12 months Lilly’s shares have increased by 75 per cent, enabling the Indianapolis-based company to surpass Johnson & Johnson as the world’s most valuable drugmaker by market capitalisation....
...Companies: 3M, General Electric, Halliburton, Johnson & Johnson, Netflix and Procter & Gamble report earnings today....
...To watch a recording of the FT’s free Isas and tax-free investing webinar featuring Claer Barrett, Moira O’Neill and Timi Merriman-Johnson, click here....
...Need to know: UK and Europe economy Former UK Prime Minister Boris Johnson breached UK government rules by failing to disclose his relationship with a hedge fund that organised his trip to meet Venezuelan...
...clot prevention medicine from Bayer and the Johnson & Johnson subsidiary Janssen Pharmaceuticals....
...Other drugmakers including Merck, Bristol Myers Squibb, and Johnson & Johnson, as well as the US pharmaceutical lobby group, have already filed lawsuits against the reforms....
...Celebrity endorsements for a new class of weight-loss drugs are mounting up, even if they do not work on Boris Johnson, incorrigible it seems in lifestyle as in politics....
...Exclusive: Johnson & Johnson’s Kenvue has been hit by claims that its talcum powder can cause cancer, days before it aims to complete the largest initial public offering in 18 months....
...He also co-led at trial against Johnson & Johnson where it was concluded that a financially engineered subsidiary, facing claims over illness caused by talcum powder, was “not sufficiently financially distressed...
...Earlier this month, Johnson & Johnson and Japanese drugmaker Astellas Pharma filed lawsuits against the Biden administration’s reforms, following on from legal challenges filed by Merck, Bristol Myers Squibb...
...Lockheed Martin, Johnson & Johnson and Albertsons also report quarterly earnings ahead of the market opening. Air carrier United Airlines will report after the bell....
...Pharmaceutical companies including AstraZeneca and Johnson and Johnson already work with the UK Biobank to access genomic data....
...Should Eli Lilly, the pharmaceuticals group, invest elsewhere if it dislikes Indiana’s strict anti-abortion policies?...
...Kenvue to begin trading: Shares in Johnson & Johnson’s consumer arm begin trading today after it raised $3.7bn in the largest IPO for 18 months....
...Cancer, stroke and diabetes medications made by Merck, Johnson & Johnson and Bristol Myers Squibb are among the first tranche of medications selected for negotiation....
...A coalition of ethical investors have asked Johnson & Johnson, Merck, Pfizer, Eli Lilly, Gilead, Amgen, Regeneron, Bristol Myers Squibb and AbbVie to publish a report on the process they follow when applying...
...US pharma group Eli Lilly is seeking approval for its obesity drug Tirzepatide, which tests have shown can slash body weight by nearly a sixth....
International Edition